{"id":"https://openalex.org/W2743566600","doi":"https://doi.org/10.1111/cas.13343","title":"Mogamulizumab for relapsed adult T\u2010cell leukemia\u2013lymphoma: Updated follow\u2010up analysis of phase I and II studies","display_name":"Mogamulizumab for relapsed adult T\u2010cell leukemia\u2013lymphoma: Updated follow\u2010up analysis of phase I and II studies","alternate_titles":[],"publication_year":2017,"publication_date":"2017-08-28","ids":{"openalex":"https://openalex.org/W2743566600","doi":"https://doi.org/10.1111/cas.13343","mag":"2743566600","pmid":"https://pubmed.ncbi.nlm.nih.gov/28776876","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5623751"},"language":"en","primary_location":{"id":"doi:10.1111/cas.13343","doi":"https://doi.org/10.1111/cas.13343","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.13343","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.13343","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2743566600"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.13343","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038817476","display_name":"Takashi Ishida","orcid":"https://orcid.org/0000-0002-1060-0777","observed_orcids":["https://orcid.org/0000-0002-1060-0777"]},"institutions":[{"id":"https://openalex.org/I33858575","display_name":"Nagoya City University","ror":"https://ror.org/04wn7wc95","country_code":"JP","type":"education","lineage":["https://openalex.org/I33858575"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Takashi Ishida","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"],"raw_orcid":"https://orcid.org/0000-0002-1060-0777","affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan","institution_ids":["https://openalex.org/I33858575","https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038965321","display_name":"Atae Utsunomiya","orcid":"https://orcid.org/0000-0002-8843-406X","observed_orcids":["https://orcid.org/0000-0002-8843-406X"]},"institutions":[{"id":"https://openalex.org/I4210125681","display_name":"Imamura Hospital","ror":"https://ror.org/02xt2gf57","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210125681"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Atae Utsunomiya","raw_affiliation_strings":["Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan","institution_ids":["https://openalex.org/I4210125681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047791149","display_name":"Tatsuro Jo","orcid":"https://orcid.org/0000-0001-5415-6228","observed_orcids":["https://orcid.org/0000-0001-5415-6228"]},"institutions":[{"id":"https://openalex.org/I4405284692","display_name":"Japanese Red Cross Nagasaki Genbaku Hospital","ror":"https://ror.org/041r2wa07","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4405284692"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tatsuro Jo","raw_affiliation_strings":["Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan","institution_ids":["https://openalex.org/I4405284692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018968800","display_name":"Kazuhito Yamamoto","orcid":"https://orcid.org/0000-0002-8588-8955","observed_orcids":["https://orcid.org/0000-0002-8588-8955"]},"institutions":[{"id":"https://openalex.org/I4210133851","display_name":"Aichi Cancer Center","ror":"https://ror.org/03kfmm080","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851"]},{"id":"https://openalex.org/I4405286927","display_name":"Aichi Cancer Center Hospital","ror":"https://ror.org/03kh0z432","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851","https://openalex.org/I4405286927"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kazuhito Yamamoto","raw_affiliation_strings":["Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan","institution_ids":["https://openalex.org/I4210133851","https://openalex.org/I4405286927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028379115","display_name":"Koji Kato","orcid":"https://orcid.org/0000-0002-5815-4585","observed_orcids":["https://orcid.org/0000-0002-5815-4585"]},"institutions":[{"id":"https://openalex.org/I135598925","display_name":"Kyushu University","ror":"https://ror.org/00p4k0j84","country_code":"JP","type":"education","lineage":["https://openalex.org/I135598925"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Koji Kato","raw_affiliation_strings":["Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan","institution_ids":["https://openalex.org/I135598925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101631852","display_name":"Shinichiro Yoshida","orcid":"https://orcid.org/0000-0003-0590-559X","observed_orcids":["https://orcid.org/0000-0003-0590-559X"]},"institutions":[{"id":"https://openalex.org/I4210118695","display_name":"Nagasaki Medical Center","ror":"https://ror.org/02qv90y91","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210118695","https://openalex.org/I4210137409"]},{"id":"https://openalex.org/I4210137409","display_name":"National Hospital Organization","ror":"https://ror.org/03ntccx93","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shinichiro Yoshida","raw_affiliation_strings":["Department of Hematology, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan","institution_ids":["https://openalex.org/I4210118695","https://openalex.org/I4210137409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005636002","display_name":"Shigeki Takemoto","orcid":"https://orcid.org/0000-0003-4130-074X","observed_orcids":["https://orcid.org/0000-0003-4130-074X"]},"institutions":[{"id":"https://openalex.org/I4210165499","display_name":"Kumamoto Medical Center","ror":"https://ror.org/05sy5w128","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4210165499"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shigeki Takemoto","raw_affiliation_strings":["Department of Hematology and Institute for Clinical Research, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan"],"raw_orcid":"https://orcid.org/0000-0003-4130-074X","affiliations":[{"raw_affiliation_string":"Department of Hematology and Institute for Clinical Research, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan","institution_ids":["https://openalex.org/I4210165499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003088921","display_name":"Hitoshi Suzushima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405253467","display_name":"Kumamoto Shinto General Hospital","ror":"https://ror.org/00pm9ra94","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253467"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hitoshi Suzushima","raw_affiliation_strings":["Department of Hematology, Kumamoto Shinto General Hospital, Kumamoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Kumamoto Shinto General Hospital, Kumamoto, Japan","institution_ids":["https://openalex.org/I4405253467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052874191","display_name":"Yukio Kobayashi","orcid":"https://orcid.org/0000-0003-2378-7865","observed_orcids":["https://orcid.org/0000-0003-2378-7865"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yukio Kobayashi","raw_affiliation_strings":["Department of Hematology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0003-2378-7865","affiliations":[{"raw_affiliation_string":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033546080","display_name":"Yoshitaka Imaizumi","orcid":"https://orcid.org/0000-0002-2954-5691","observed_orcids":["https://orcid.org/0000-0002-2954-5691"]},"institutions":[{"id":"https://openalex.org/I4405285995","display_name":"Atomic Bomb Disease Institute, Nagasaki University","ror":"https://ror.org/00wc6zv93","country_code":"JP","type":"facility","lineage":["https://openalex.org/I43777268","https://openalex.org/I4405285995"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshitaka Imaizumi","raw_affiliation_strings":["Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki, Japan","institution_ids":["https://openalex.org/I4405285995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044214575","display_name":"Kenichi Yoshimura","orcid":"https://orcid.org/0000-0001-7393-6932","observed_orcids":["https://orcid.org/0000-0001-7393-6932"]},"institutions":[{"id":"https://openalex.org/I10091056","display_name":"Kanazawa University","ror":"https://ror.org/02hwp6a56","country_code":"JP","type":"education","lineage":["https://openalex.org/I10091056"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenichi Yoshimura","raw_affiliation_strings":["Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan","institution_ids":["https://openalex.org/I10091056"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kouichi Kawamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kouichi Kawamura","raw_affiliation_strings":["Department of Medical Affairs, Kyowa Hakko Kirin Co., Ltd, Otemachi Financial City Grand Cube, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Affairs, Kyowa Hakko Kirin Co., Ltd, Otemachi Financial City Grand Cube, Tokyo, Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062035100","display_name":"Takeshi Takahashi","orcid":"https://orcid.org/0000-0002-3898-5883","observed_orcids":["https://orcid.org/0000-0002-3898-5883"]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takeshi Takahashi","raw_affiliation_strings":["Department of Medical Affairs, Kyowa Hakko Kirin Co., Ltd, Otemachi Financial City Grand Cube, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Affairs, Kyowa Hakko Kirin Co., Ltd, Otemachi Financial City Grand Cube, Tokyo, Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036000764","display_name":"Kensei Tobinai","orcid":"https://orcid.org/0000-0002-7859-3227","observed_orcids":["https://orcid.org/0000-0002-7859-3227"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kensei Tobinai","raw_affiliation_strings":["Department of Hematology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015338865","display_name":"Ryuzo Ueda","orcid":"https://orcid.org/0000-0003-1120-1142","observed_orcids":["https://orcid.org/0000-0003-1120-1142"]},"institutions":[{"id":"https://openalex.org/I16528096","display_name":"Aichi Medical University","ror":"https://ror.org/02h6cs343","country_code":"JP","type":"education","lineage":["https://openalex.org/I16528096"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ryuzo Ueda","raw_affiliation_strings":["Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I16528096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":16,"corresponding_author_ids":["https://openalex.org/A5038817476"],"corresponding_institution_ids":["https://openalex.org/I33858575","https://openalex.org/I60134161"],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":{"value":2600,"currency":"USD","value_usd":2600},"fwci":4.401,"has_fulltext":true,"cited_by_count":76,"citation_normalized_percentile":{"value":0.95741585,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"108","issue":"10","first_page":"2022","last_page":"2029"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mogamulizumab","display_name":"mogamulizumab","score":1.0},{"id":"https://openalex.org/keywords/adult-t-cell-leukemia-lymphoma","display_name":"adult T-cell leukemia/lymphoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/relapsed-disease","display_name":"relapsed disease","score":0.8259999752044678},{"id":"https://openalex.org/keywords/anti-ccr4-monoclonal-antibody","display_name":"anti-CCR4 monoclonal antibody","score":0.9279999732971191},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8809999823570251},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.7749999761581421},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9940000176429749},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7910000085830688}],"concepts":[{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.8786091208457947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8204838037490845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7011298537254333},{"id":"https://openalex.org/C2780815077","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Adult T-cell leukemia/lymphoma","level":4,"score":0.609600841999054},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5595895051956177},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5542457103729248},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4124116003513336},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3531111776828766},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34745949506759644},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3437615633010864},{"id":"https://openalex.org/C2776913467","wikidata":"https://www.wikidata.org/wiki/Q7667895","display_name":"T-cell leukemia","level":3,"score":0.19392302632331848}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015459","descriptor_name":"Leukemia-Lymphoma, Adult T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/cas.13343","doi":"https://doi.org/10.1111/cas.13343","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.13343","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.13343","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4551261","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5623751","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5623751","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5623751/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Sci","raw_type":"Text"},{"id":"pmid:28776876","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28776876","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer science","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1111/cas.13343","doi":"https://doi.org/10.1111/cas.13343","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.13343","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.13343","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1331949990","display_name":"Mogamulizumab induced immune related adverse events; the impact of Treg depletion","funder_award_id":"16H04713","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G1499466379","display_name":"Relationship between NfkB signaling and epigeneteic signaling in malignant lymphoma.","funder_award_id":"16K09865","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G2195492961","display_name":"The lymphoma microenvironment is a novel therapeutic target in the treatment of patients with B-cell lymphoma","funder_award_id":"16K09875","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320322359","display_name":"Kyowa Hakko Kirin","ror":"https://ror.org/0586k5242"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2743566600.pdf","grobid_xml":"https://content.openalex.org/works/W2743566600.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1597238753","https://openalex.org/W1849097877","https://openalex.org/W1906100218","https://openalex.org/W1909862186","https://openalex.org/W1988087661","https://openalex.org/W1995670792","https://openalex.org/W2000302977","https://openalex.org/W2001356431","https://openalex.org/W2009621572","https://openalex.org/W2011458181","https://openalex.org/W2054738595","https://openalex.org/W2057091812","https://openalex.org/W2057910076","https://openalex.org/W2064046777","https://openalex.org/W2069044509","https://openalex.org/W2080959198","https://openalex.org/W2084136419","https://openalex.org/W2085793467","https://openalex.org/W2099464793","https://openalex.org/W2102113607","https://openalex.org/W2104681031","https://openalex.org/W2109847786","https://openalex.org/W2110220145","https://openalex.org/W2110890034","https://openalex.org/W2113158224","https://openalex.org/W2119092367","https://openalex.org/W2120644528","https://openalex.org/W2121304964","https://openalex.org/W2132428017","https://openalex.org/W2132768813","https://openalex.org/W2151512910","https://openalex.org/W2153633245","https://openalex.org/W2158377087","https://openalex.org/W2158552371","https://openalex.org/W2166075265","https://openalex.org/W2166989515","https://openalex.org/W2170522323","https://openalex.org/W2179179825","https://openalex.org/W2184668473","https://openalex.org/W2293723101","https://openalex.org/W2310716991","https://openalex.org/W2319072320","https://openalex.org/W2336865896","https://openalex.org/W2416844197","https://openalex.org/W2494933951","https://openalex.org/W2505265838","https://openalex.org/W2519997684"],"related_works":["https://openalex.org/W3036436856","https://openalex.org/W2604644782","https://openalex.org/W2583307538","https://openalex.org/W2912166265","https://openalex.org/W2905627019","https://openalex.org/W2001356431","https://openalex.org/W2109160803","https://openalex.org/W2597991926","https://openalex.org/W2624145351","https://openalex.org/W2066956683"],"abstract_inverted_index":{"The":[0],"present":[1,218],"study":[2,42,58],"sought":[3],"to":[4,215,221],"elucidate":[5],"the":[6,70,87,217,223,227],"prognosis":[7],"of":[8,28,43,139,145,171,177,229],"adult":[9],"T-cell":[10,52],"leukemia-lymphoma":[11],"(ATL)":[12],"patients":[13,30,47,64,82,113,150,192],"receiving":[14],"mogamulizumab,":[15],"a":[16,115,120,136,153,168,201,205],"defucosylated":[17],"anti-CCR4":[18],"monoclonal":[19],"antibody.":[20],"Progression-free":[21],"survival":[22,26],"(PFS)":[23],"and":[24,50,54,96,107,130,142,162,174,188,220],"overall":[25],"(OS)":[27],"ATL":[29,49,68,85],"enrolled":[31],"in":[32,45,69,86,190,226],"two":[33],"studies":[34],"are":[35],"herein":[36],"updated,":[37],"namely":[38],"NCT00355472":[39],"(phase":[40,56],"I":[41,72],"mogamulizumab":[44,183],"relapsed":[46,60,66,81,194],"with":[48,65,83,135,167,193],"peripheral":[51],"lymphoma)":[53],"NCT00920790":[55],"II":[57,89],"for":[59,149],"ATL).":[61],"Of":[62],"13":[63],"aggressive":[67,84,195],"phase":[71,88],"study,":[73,90],"four":[74],"(31%)":[75],"survived":[76],">3":[77],"years.":[78],"For":[79,112],"26":[80],"median":[91,102,125,137,157,169],"PFS":[92,98,126,132,158,164,187],"was":[93,99,104,110,127,133,159,165],"5.2":[94],"months":[95],"1-year":[97,131,163],"26%,":[100],"whereas":[101],"OS":[103,109,138,144,170,176,189],"14.4":[105],"months,":[106,129,141,161,173],"3-year":[108,143,175],"23%.":[111],"without":[114],"rash":[116,123,154,203],"or":[117],"who":[118,151,199],"developed":[119,152],"grade":[121],"1":[122],"only,":[124],"0.8":[128],"zero,":[134],"6.0":[140],"8%.":[146],"In":[147],"contrast,":[148],"\u2265grade":[155],"2,":[156],"11.7":[160],"50%,":[166],"25.6":[172],"36%.":[178],"Thus,":[179],"we":[180],"conclude":[181],"that":[182],"monotherapy":[184],"may":[185],"improve":[186],"some":[191],"ATL,":[196],"especially":[197],"those":[198],"develop":[200],"skin":[202],"as":[204],"moderate":[206],"immune-related":[207],"adverse":[208],"event.":[209],"Therefore,":[210],"further":[211],"investigation":[212],"is":[213],"warranted":[214],"validate":[216],"observations":[219],"clarify":[222],"mechanisms":[224],"involved":[225],"activity":[228],"mogamulizumab.":[230]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2743566600","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-08-17T00:00:00"}
